We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals
RCKT

178 hedge funds and large institutions have $1.96B invested in Rocket Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 74 increasing their positions, 50 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $5.17M | Put options by funds: $3.15M

48% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 50

1.56% less ownership

Funds ownership: 102.06% → 100.51% (-1.6%)

4% less funds holding

Funds holding: 186 → 178 (-8)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

21% less capital invested

Capital invested by funds: $2.48B → $1.96B (-$522M)

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

Holders
178
Holders Change
-8
Holders Change %
-4.3%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
21
Increased
74
Reduced
50
Closed
27
Calls
$5.17M
Puts
$3.15M
Net Calls
+$2.02M
Net Calls Change
-$15.1M

Top Buyers

1
WP
Woodline Partners
California
+$12.9M
2
EC
EcoR1 Capital
California
+$11.7M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$10.1M
4
Citadel Advisors
Citadel Advisors
Florida
+$8M
5
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$7.9M

Top Sellers

1
ACA
Avoro Capital Advisors
New York
-$34M
2
State Street
State Street
Massachusetts
-$32.5M
3
LGM
Logos Global Management
California
-$21.8M
4
PA
Perceptive Advisors
New York
-$12.7M
5
CAM
Cormorant Asset Management
Massachusetts
-$8.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Comerica Bank
26
Comerica Bank
Texas
$14.8M +$3.49M +152,129 +28%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$14.6M +$45.4K +1,975 +0.3%
Northern Trust
28
Northern Trust
Illinois
$12.7M -$492K -21,440 -4%
JP Morgan Chase
29
JP Morgan Chase
New York
$12.5M -$2.36M -102,786 -15%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$12.5M +$60K +2,612 +0.5%
WP
31
Woodline Partners
California
$12.1M +$12.9M +561,966 New
FTM
32
First Turn Management
California
$12.1M +$7.12M +310,119 +124%
Charles Schwab
33
Charles Schwab
California
$11.8M +$389K +16,929 +3%
EC
34
EcoR1 Capital
California
$10.9M +$11.7M +508,393 New
Morgan Stanley
35
Morgan Stanley
New York
$10.2M -$4.89M -212,825 -31%
UBS Group
36
UBS Group
Switzerland
$8.74M -$2.37M -103,172 -20%
Schroder Investment Management Group
37
Schroder Investment Management Group
United Kingdom
$8.33M +$2.56M +111,276 +40%
MCM
38
M28 Capital Management
Connecticut
$8.3M – – –
Invesco
39
Invesco
Georgia
$7.58M +$7.14M +310,836 +755%
LGM
40
Logos Global Management
California
$7.54M -$21.8M -950,000 -73%
WCM Investment Management
41
WCM Investment Management
California
$6.28M -$109K -4,757 -2%
AllianceBernstein
42
AllianceBernstein
Tennessee
$5.63M +$2.44M +106,103 +68%
ACP
43
Acuta Capital Partners
California
$5.39M -$1.76M -76,417 -23%
Bank of New York Mellon
44
Bank of New York Mellon
New York
$5.16M +$517K +22,521 +10%
PFM
45
Privium Fund Management
Netherlands
$4.96M +$366K +15,930 +7%
EAM
46
EFG Asset Management
Oregon
$4.78M +$1.63M +71,044 +47%
SFM
47
Sphera Funds Management
Israel
$4.46M +$533K +23,211 +13%
HWAM
48
Hennion & Walsh Asset Management
New Jersey
$4.39M -$624K -27,177 -12%
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$4.31M +$1.61M +70,000 +54%
Mirae Asset Global ETFs Holdings
50
Mirae Asset Global ETFs Holdings
Hong Kong
$4.28M +$4.57M +198,771 New
1
2
3 4 5

RCKT Hedge Fund Activity: Q2 2024 in Review

178 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals (RCKT) for Q2 2024, worth a combined $1.96B — down 21% from $2.48B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of RCKT and 21 opened new positions — a net loss of 6 holders — while 50 trimmed existing stakes and 74 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $12.9M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $34M sold.

  • 178 institutional investors held Rocket Pharmaceuticals (RCKT) as of Q2 2024, down from 186 in Q1 2024.
  • Funds reported $1.96B of Rocket Pharmaceuticals stock for Q2 2024, down 21% quarter-over-quarter.
  • 21 funds opened new Rocket Pharmaceuticals positions in Q2 2024 and 27 closed out, a net change of -6 holders.
  • The largest Rocket Pharmaceuticals buyer in Q2 2024 was Woodline Partners, an estimated $12.9M added.
  • The largest Rocket Pharmaceuticals seller in Q2 2024 was Avoro Capital Advisors, an estimated $34M sold.

Based on aggregated 13F filings for Q2 2024.